← Back to Search

Prostate biopsy for Prostate Cancer

N/A
Waitlist Available
Led By Neil E Martin, MD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline biopsy to final mri, up to 18 months
Awards & highlights

Study Summary

This trial is looking at how accurate MRI scans are at identifying which men with prostate cancer are good candidates for active surveillance, in order to avoid unnecessary treatment.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline biopsy to final mri, up to 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline biopsy to final mri, up to 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
MP- erMRI Classification Specificity
MP-erMRI Classification Sensitivity
Secondary outcome measures
Disease Extent by Classification Status
Frequency of Reclassification
Gleason Score by Classification Status
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Accuracy of multi-parametric MRI relative to prostate biopsyExperimental Treatment2 Interventions
Determine the sensitivity and specificity of MP-erMRI relative to repeat 12 core TRUS biopsy for classifying upgrading of disease extent or Gleason grade in men considering AS.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Multiparametric MRI
2013
N/A
~110
Prostate biopsy
2013
N/A
~660

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,078 Previous Clinical Trials
340,771 Total Patients Enrolled
76 Trials studying Prostate Cancer
16,004 Patients Enrolled for Prostate Cancer
Neil E Martin, MDPrincipal InvestigatorDana-Farber Cancer Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer
Neil Martin, MD 2013. "A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01858688.
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top